Admission of Shares and Total Voting Rights
Oxford Biomedica PLC (OXB) announced the admission of 13,921,114 new ordinary shares to the London Stock Exchange's main market on August 20, 2025. Following this admission, the company's issued share capital totals 120,173,462 ordinary shares, with no shares held in treasury. Therefore, the total number of voting rights in OXB is 120,173,462.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 20 August 2025: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today provides an update to the announcement made on 15 August 2025 regarding the successful Placing and Subscription of new Ordinary Shares.
The Company confirms that 13,921,114 new Ordinary Shares of 50 pence each will be admitted at 8.00 a.m. (London time) today to the Equity Shares (Commercial Companies) segment of the Official List and to trading on the Main Market of the London Stock Exchange (the "Admission").
Following the Admission, the Company's issued share capital will consist of 120,173,462 ordinary shares of 50 pence each ("Ordinary Shares"), and there will remain no Ordinary Shares held in treasury.
Accordingly, the total number of voting rights in OXB at the date of this notice, following the Admission, is 120,173,462.
The above figure 120,173,462 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, OXB under the FCA's Disclosure Guidance and Transparency Rules.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.